These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 15106750

  • 1. Diabetic cardiomyopathy.
    Feuvray D.
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):261-5. PubMed ID: 15106750
    [Abstract] [Full Text] [Related]

  • 2. Diabetes-related metabolic perturbations in cardiac myocyte.
    Feuvray D, Darmellah A.
    Diabetes Metab; 2008 Feb; 34 Suppl 1():S3-9. PubMed ID: 18358420
    [Abstract] [Full Text] [Related]

  • 3. Alterations in energy metabolism in cardiomyopathies.
    Taha M, Lopaschuk GD.
    Ann Med; 2007 Feb; 39(8):594-607. PubMed ID: 17934906
    [Abstract] [Full Text] [Related]

  • 4. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy.
    Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N, Evans RM, Schneider MD, Brako FA, Xiao Y, Chen YE, Yang Q.
    Nat Med; 2004 Nov; 10(11):1245-50. PubMed ID: 15475963
    [Abstract] [Full Text] [Related]

  • 5. Insulin signalling in the heart.
    Bertrand L, Horman S, Beauloye C, Vanoverschelde JL.
    Cardiovasc Res; 2008 Jul 15; 79(2):238-48. PubMed ID: 18390897
    [Abstract] [Full Text] [Related]

  • 6. Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin.
    Tokarska-Schlattner M, Wallimann T, Schlattner U.
    C R Biol; 2006 Sep 15; 329(9):657-68. PubMed ID: 16945832
    [Abstract] [Full Text] [Related]

  • 7. Convergence of glucose- and fatty acid-induced abnormal myocardial excitation-contraction coupling and insulin signalling.
    Davidoff AJ.
    Clin Exp Pharmacol Physiol; 2006 Sep 15; 33(1-2):152-8. PubMed ID: 16445715
    [Abstract] [Full Text] [Related]

  • 8. AMP-activated protein kinase in the heart: role during health and disease.
    Arad M, Seidman CE, Seidman JG.
    Circ Res; 2007 Mar 02; 100(4):474-88. PubMed ID: 17332438
    [Abstract] [Full Text] [Related]

  • 9. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates.
    Jobgen WS, Fried SK, Fu WJ, Meininger CJ, Wu G.
    J Nutr Biochem; 2006 Sep 02; 17(9):571-88. PubMed ID: 16524713
    [Abstract] [Full Text] [Related]

  • 10. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG, Jung DY, Ko HJ, Zhang Z, Ma Z, Jun JY, Kim JH, Sumner AD, Vary TC, Gardner TW, Bronson SK, Kim JK.
    Am J Physiol Endocrinol Metab; 2007 Dec 02; 293(6):E1687-96. PubMed ID: 17911348
    [Abstract] [Full Text] [Related]

  • 11. Nuclear receptor signaling and cardiac energetics.
    Huss JM, Kelly DP.
    Circ Res; 2004 Sep 17; 95(6):568-78. PubMed ID: 15375023
    [Abstract] [Full Text] [Related]

  • 12. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
    Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM.
    Diabetes; 2006 Aug 17; 55(8):2277-85. PubMed ID: 16873691
    [Abstract] [Full Text] [Related]

  • 13. Acute effect of antidiabetic 1,4-dihydropyridine compound cerebrocrast on cardiac function and glucose metabolism in the isolated, perfused normal rat heart.
    Briede J, Stivrina M, Vigante B, Stoldere D, Duburs G.
    Cell Biochem Funct; 2008 Aug 17; 26(2):238-45. PubMed ID: 17990288
    [Abstract] [Full Text] [Related]

  • 14. Reactive oxygen species and insulin-resistant cardiomyopathy.
    Mellor KM, Ritchie RH, Delbridge LM.
    Clin Exp Pharmacol Physiol; 2010 Feb 17; 37(2):222-8. PubMed ID: 19671065
    [Abstract] [Full Text] [Related]

  • 15. Insulin status differentially affects energy transduction in cardiac mitochondria from male and female rats.
    Billimoria FR, Katyare SS, Patel SP.
    Diabetes Obes Metab; 2006 Jan 17; 8(1):67-74. PubMed ID: 16367884
    [Abstract] [Full Text] [Related]

  • 16. Transcriptomic analysis of the cardiac left ventricle in a rodent model of diabetic cardiomyopathy: molecular snapshot of a severe myocardial disease.
    Glyn-Jones S, Song S, Black MA, Phillips AR, Choong SY, Cooper GJ.
    Physiol Genomics; 2007 Feb 12; 28(3):284-93. PubMed ID: 17062650
    [Abstract] [Full Text] [Related]

  • 17. Free fatty acids and skeletal muscle insulin resistance.
    Kraegen EW, Cooney GJ.
    Curr Opin Lipidol; 2008 Jun 12; 19(3):235-41. PubMed ID: 18460913
    [Abstract] [Full Text] [Related]

  • 18. Metabolic toxicity of the heart: insights from molecular imaging.
    Iozzo P.
    Nutr Metab Cardiovasc Dis; 2010 Mar 12; 20(3):147-56. PubMed ID: 20031381
    [Abstract] [Full Text] [Related]

  • 19. AMP-activated protein kinase: a key stress signaling pathway in the heart.
    Young LH, Li J, Baron SJ, Russell RR.
    Trends Cardiovasc Med; 2005 Apr 12; 15(3):110-8. PubMed ID: 16039971
    [Abstract] [Full Text] [Related]

  • 20. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N, Bruce CR, Beale SM, Hoehn KL, So T, Rolph MS, Cooney GJ.
    Diabetes; 2007 Aug 12; 56(8):2085-92. PubMed ID: 17519422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.